SUSMED (4263) Stock Overview

SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

4263 Stock Information

Symbol

4263

Address

MFPR Nihonbashi honcho BldgTokyo, 103-0023Japan

Founded

Trading hours

Website

https://www.susmed.co.jp

Country

🇯🇵 Japan

Phone Number

81 3 6366 7780

SUSMED (4263) Price Chart

SUSMED Overview: Key Details and Summary

Stock data	2023	Change
Price	$3.71	N/A
Market Cap	$60.82M	N/A
Shares Outstanding	16.40M	11.71%
Employees	33.00	N/A
Shareholder Equity	4.87B	0.42%

Valuation	2023	Change
P/E Ratio	-1.20	N/A
P/S Ratio	17.93	N/A
P/B Ratio	0.01	N/A

Growth	2023	Change
Return on Equity	-0.0001	N/A

Earnings	2023	Change
Revenue	$3.39M	N/A
Earnings	-$324.45K	N/A
EPS	-3.09	N/A
Earnings Yield	-0.8333	N/A
Gross Margin	0.9849	N/A
Operating Margin	-0.091	N/A
Net income margin	-0.0956	N/A

Financial Strength	2023	Change
Total Assets	$32.61M	N/A
Cash on Hand	$32.28M	N/A
Debt to Equity	0.0003	145.73%
Current Ratio	$22.63	-59.79%